Perspective Therapeutics, Inc. (CATX)
0.7362
-0.04
(-5.63%)
USD |
NYAM |
Nov 19, 15:30
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 84.05M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -65.79% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 350.82 |
| Price to Book Value | 0.2852 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.0125 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 93.75% |
Profile
| Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded by Michael K. Schultz in 1983 and is headquartered in Seattle, WA. |
| URL | http://perspectivetherapeutics.com |
| Investor Relations URL | https://perspectivetherapeutics.com/investors |
| HQ State/Province | Washington |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap Growth |
| Next Earnings Release | Mar. 15, 2027 (est.) |
| Last Earnings Release | Nov. 09, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded by Michael K. Schultz in 1983 and is headquartered in Seattle, WA. |
| URL | http://perspectivetherapeutics.com |
| Investor Relations URL | https://perspectivetherapeutics.com/investors |
| HQ State/Province | Washington |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap Growth |
| Next Earnings Release | Mar. 15, 2027 (est.) |
| Last Earnings Release | Nov. 09, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |